Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% Monotherapy in Vitiligo
NCT03358082Phase 2Unknown
- Sponsor
- Sohag University
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Tacrolimus Ointment 0.1% Iwaki in Vitiligo (2 arms), sponsored by Sohag University. Primary endpoint: Vitiligo Area Scoring Index at 9 months. Status: unknown.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03358082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358082.